Skip to main content
Search

Humboldt-Universität zu Berlin

3 related articles

Subscribe to updates
  1. medRxiv

    Ewing sarcoma survival splits by neighborhood, not mutation: a 135-patient spatial map yields four prognostic types, with interferon-reactive tumors faring best

    Ewing sarcoma is genomically near-uniform yet patients fare very differently. Single-cell and spatial transcriptomics of tumors and their microenvironment in 135 patients identified five tumor-cell transcriptional states and eight niches defined by neighboring cell configurations, and niche composition sorted patients into Fusion Active, Proliferative, Immune Reactive and TME-enriched types. The Immune Reactive type, marked by interferon-activated tumor cells, had favorable survival, and the survival differences reproduced in two independent bulk transcriptomic cohorts.

  2. Nature Methods

    Spatial proteomics gets an open-source path from whole-slide image to mass spec, with neighborhood sampling about 100 times faster

    Deep visual proteomics (DVP) lacked an open-source end-to-end workflow, which limited adoption and systematic benchmarking. openDVP links image processing, cell phenotyping, laser microdissection and mass-spectrometry proteomics into a modular pipeline, with a fast-track route that needs no image-analysis expertise. Across archival placenta, early lung cancer and relapsed breast cancer tissue, neighborhood-guided sampling collected tissue about 100 times faster than single-cell cutting and raised protein identifications by an average of 26%.

  3. medRxiv

    The Multimodal Anonymizer: a fully local multi-agent AI system for medical data deidentification

    The study developed and evaluated the Multimodal Anonymizer, a modular, locally deployable multi-agent framework integrating multimodal large language models, task-specific neural networks, and rule-based transformations; on benchmarks spanning text, tables, PDFs, imaging, metadata, filenames, audio, handwriting, and 3D imaging, its best local configuration (orchestrator Qwen3-VL-235B-A22B-Thinking) achieved 98.80% per-patient deidentification sensitivity (95%-CI 97.20; 100) and 99.60% critical clinical preservation (95%-CI 98.80; 100), reached 100% sensitivity and critical preservation on 250 local Charité partograms, and outperformed established tools across most modalities.

You’re all caught up